These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17522564)

  • 1. The safety and efficacy of ECT and anesthesia in the setting of multiple sclerosis.
    Fitzsimons MG; Welch CA; Haspel KL; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):195-8. PubMed ID: 17522564
    [No Abstract]   [Full Text] [Related]  

  • 2. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy in pregnancy.
    Pinette MG; Santarpio C; Wax JR; Blackstone J
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):465-6. PubMed ID: 17666629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis.
    Coret F; Bosca I; Landete L; Magraner MJ; Navarré A; León JL; Casanova B
    Mult Scler; 2010 Aug; 16(8):935-41. PubMed ID: 20573640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
    Urban-Kowalczyk M; Rudecki T; Wróblewski D; Smigielski J; Kałużyńska O; Rabe-Jabłońska J
    Neurocase; 2014 Aug; 20(4):452-5. PubMed ID: 23679561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of therapy in patients with multiple sclerosis].
    Kümpfel T; Havla J; Hohlfeld R
    MMW Fortschr Med; 2010 Mar; 152(9):42-4. PubMed ID: 20384096
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral posterior vitreous detachment after electroconvulsive therapy.
    Martínez-Amorós E; Real Barrero E; Fuste Fusares C; Hernández-Ribas R; Urretavizcaya Sarachaga M
    Gen Hosp Psychiatry; 2009; 31(4):385-7. PubMed ID: 19555802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to ECT in bipolar I, bipolar II and unipolar depression.
    Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
    J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
    O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
    J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy: an overview.
    Solomon JG
    Va Med; 1979 Apr; 106(5):280-2, 287-8. PubMed ID: 441398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
    Rose JW; Burns JB; Bjorklund J; Klein J; Watt HE; Carlson NG
    Neurology; 2007 Aug; 69(8):785-9. PubMed ID: 17709711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy in a patient with a cerebellar meningioma.
    McKinney PA; Beale MD; Kellner CH
    J ECT; 1998 Mar; 14(1):49-52. PubMed ID: 9661094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe use of ECT with an intracranial aneurysm.
    Gardner MW; Kellner CH
    J ECT; 1998 Dec; 14(4):290-2. PubMed ID: 9871855
    [No Abstract]   [Full Text] [Related]  

  • 15. No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen N
    Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
    [No Abstract]   [Full Text] [Related]  

  • 16. Onset of multiple sclerosis following post-partum depressive and manic episodes.
    Akkaya C; Kocagoz SZ; Turan OF; Taskapilioglu O; Kirli S
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):698-9. PubMed ID: 18081637
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
    Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroshock: a discerning review of the nursing literature.
    Daalen-Smith CL; Gallagher J
    Issues Ment Health Nurs; 2011; 32(4):203-13. PubMed ID: 21355754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.